The Technical Analyst
U.S. Stem Cell, Inc. [USRM]
Exchange: OTC Sector: Healthcare Industry: Biotechnology
U.S. Stem Cell, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% $0.0000
America/New_York / 2 mai 2024 @ 15:42
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 0.0006 mill |
| EPS: | -0.0100 |
| P/E: | 0 |
| Earnings Date: | May 08, 2024 |
| SharesOutstanding: | 641.51 mill |
| Avg Daily Volume: | 0.0079 mill |
| RATING 2024-05-02 |
|---|
| C+ |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Sell | |
| Return On Equity: | Sell | |
| Return On Asset: | Neutral | |
| DE: | Sell | |
| P/E: | Neutral | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
| Revenue | n/a | n/a | ||||
| Gr.Profit | n/a | n/a | ||||
| Ebit | n/a | n/a | ||||
| Asset | n/a | n/a | ||||
| Debt | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 0 | sector: PE 29.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| N/A |
| Company: PE 0 | industry: PE 136.10 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.0000 - 0.0000 ( +/- 0.00%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2022-04-25 | Knutson Gregory | Buy | 2 500 000 | Common Stock |
| 2022-03-18 | Knutson Gregory | Buy | 25 000 000 | Common Stock |
| 2022-02-24 | Knutson Gregory | Buy | 12 500 000 | Warrant |
| 2022-02-24 | Knutson Gregory | Buy | 12 500 000 | Convertible promissory Note (right to buy) |
| 2021-03-23 | Murphy William P Jr | Buy | 7 518 797 | Common Stock |
| INSIDER POWER |
|---|
| 100.00 |
| Last 99 transactions |
| Buy: 237 671 429 | Sell: 625 000 |
Forecast: